{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:40:24Z","timestamp":1761975624758,"version":"3.41.0"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,5,31]],"date-time":"2017-05-31T00:00:00Z","timestamp":1496188800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1038\/npp.2017.110","type":"journal-article","created":{"date-parts":[[2017,5,31]],"date-time":"2017-05-31T11:00:53Z","timestamp":1496228453000},"page":"2141-2151","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Gamma-Hydroxybutyrate Increases Resting-State Limbic Perfusion and Body and Emotion Awareness in Humans"],"prefix":"10.1038","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5807-0859","authenticated-orcid":false,"given":"Oliver G","family":"Bosch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5099-9786","authenticated-orcid":false,"given":"Fabrizio","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael M","family":"Havranek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dario","family":"Dornbierer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"von Rotz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Staempfli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7933-2865","authenticated-orcid":false,"given":"Boris B","family":"Quednow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erich","family":"Seifritz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,31]]},"reference":[{"key":"BFnpp2017110_CR1","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1196\/annals.1369.065","volume":"1074","author":"S Abanades","year":"2006","unstructured":"Abanades S, Farre M, Segura M, Pichini S, Barral D, Pacifici R et al (2006). Gamma-hydroxybutyrate (GHB) in humans: pharmacodynamics and pharmacokinetics. Ann N Y Acad Sci 1074: 559\u2013576.","journal-title":"Ann N Y Acad Sci"},{"key":"BFnpp2017110_CR2","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1159\/000347055","volume":"19","author":"R Agabio","year":"2013","unstructured":"Agabio R, Preti A, Gessa GL (2013). Efficacy and tolerability of baclofen in substance use disorders: a systematic review. Eur Addic Res 19: 325\u2013345.","journal-title":"Eur Addic Res"},{"key":"BFnpp2017110_CR3","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/mrm.25197","volume":"73","author":"DC Alsop","year":"2015","unstructured":"Alsop DC, Detre JA, Golay X, Gunther M, Hendrikse J, Hernandez-Garcia L et al (2015). Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: a consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia. Magn Reson Med 73: 102\u2013116.","journal-title":"Magn Reson Med"},{"key":"BFnpp2017110_CR4","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/dta.254","volume":"3","author":"H Andresen","year":"2011","unstructured":"Andresen H, Aydin BE, Mueller A, Iwersen-Bergmann S (2011). An overview of gamma-hydroxybutyric acid: pharmacodynamics, pharmacokinetics, toxic effects, addiction, analytical methods, and interpretation of results. Drug Test Anal 3: 560\u2013568.","journal-title":"Drug Test Anal"},{"key":"BFnpp2017110_CR5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/02791072.2007.10399870","volume":"39","author":"JC Barker","year":"2007","unstructured":"Barker JC, Harris SL, Dyer JE (2007). Experiences of gamma hydroxybutyrate (GHB) ingestion: a focus group study. J Psychoactive Drugs 39: 115\u2013129.","journal-title":"J Psychoactive Drugs"},{"key":"BFnpp2017110_CR6","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/0024-3205(82)90624-5","volume":"30","author":"J Benavides","year":"1982","unstructured":"Benavides J, Rumigny JF, Bourguignon JJ, Cash C, Wermuth CG, Mandel P et al (1982). High affinity binding sites for gamma-hydroxybutyric acid in rat brain. Life Sci 30: 953\u2013961.","journal-title":"Life Sci"},{"key":"BFnpp2017110_CR7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0169-328X(00)00047-4","volume":"77","author":"A Billinton","year":"2000","unstructured":"Billinton A, Ige AO, Wise A, White JH, Disney GH, Marshall FH et al (2000). GABA(B) receptor heterodimer-component localisation in human brain. Brain Res Mol Brain Res 77: 111\u2013124.","journal-title":"Brain Res Mol Brain Res"},{"key":"BFnpp2017110_CR8","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1037\/emo0000057","volume":"15","author":"MT Boden","year":"2015","unstructured":"Boden MT, Thompson RJ (2015). Facets of emotional awareness and associations with emotion regulation and depression. Emotion 15: 399\u2013410.","journal-title":"Emotion"},{"key":"BFnpp2017110_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psyneuen.2015.07.167","volume":"62","author":"OG Bosch","year":"2015","unstructured":"Bosch OG, Eisenegger C, Gertsch J, von Rotz R, Dornbierer D, Gachet MS et al (2015). Gamma-hydroxybutyrate enhances mood and prosocial behavior without affecting plasma oxytocin and testosterone. Psychoneuroendocrinology 62: 1\u201310.","journal-title":"Psychoneuroendocrinology"},{"key":"BFnpp2017110_CR10","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.euroneuro.2017.02.006","volume":"27","author":"OG Bosch","year":"2017","unstructured":"Bosch OG, Havranek MM, Baumberger A, Preller KH, von Rotz R, Herdener M et al (2017). Neural underpinnings of prosexual effects induced by gamma-hydroxybutyrate in healthy male humans. Eur Neuropsychopharmacol 27: 372\u2013382.","journal-title":"Eur Neuropsychopharmacol"},{"key":"BFnpp2017110_CR11","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1177\/0269881111421975","volume":"26","author":"OG Bosch","year":"2012","unstructured":"Bosch OG, Quednow BB, Seifritz E, Wetter TC (2012). Reconsidering GHB: orphan drug or new model antidepressant? J Psychopharmacol 26: 618\u2013628.","journal-title":"J Psychopharmacol"},{"key":"BFnpp2017110_CR12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.brainresbull.2016.02.002","volume":"47","author":"OG Bosch","year":"2016","unstructured":"Bosch OG, Seifritz E (2016). The behavioural profile of gamma-hydroxybutyrate, gamma-butyrolactone and 1,4-butanediol in humans. Brain Res Bull 47: 47\u201360.","journal-title":"Brain Res Bull"},{"key":"BFnpp2017110_CR13","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/mrm.1910400308","volume":"40","author":"RB Buxton","year":"1998","unstructured":"Buxton RB, Frank LR, Wong EC, Siewert B, Warach S, Edelman RR (1998). A general kinetic model for quantitative perfusion imaging with arterial spin labeling. Magn Reson Med 40: 383\u2013396.","journal-title":"Magn Reson Med"},{"key":"BFnpp2017110_CR14","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.pharmthera.2008.10.003","volume":"121","author":"LP Carter","year":"2009","unstructured":"Carter LP, Koek W, France CP (2009). Behavioral analyses of GHB: receptor mechanisms. Pharmacol Therap 121: 100\u2013114.","journal-title":"Pharmacol Therap"},{"key":"BFnpp2017110_CR15","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/clpt.2010.296","volume":"89","author":"Y Chen","year":"2011","unstructured":"Chen Y, Wan HI, O'Reardon JP, Wang DJ, Wang Z, Korczykowski M et al (2011). Quantification of cerebral blood flow as biomarker of drug effect: arterial spin labeling phMRI after a single dose of oral citalopram. Clin Pharmacol Therap 89: 251\u2013258.","journal-title":"Clin Pharmacol Therap"},{"key":"BFnpp2017110_CR16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1037\/0033-2909.109.1.25","volume":"109","author":"D Cioffi","year":"1991","unstructured":"Cioffi D (1991). Beyond attentional strategies: cognitive-perceptual model of somatic interpretation. Psychol Bull 109: 25\u201341.","journal-title":"Psychol Bull"},{"key":"BFnpp2017110_CR17","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.nicl.2016.06.022","volume":"12","author":"WJ Cottam","year":"2016","unstructured":"Cottam WJ, Condon L, Alshuft H, Reckziegel D, Auer DP (2016). Associations of limbic-affective brain activity and severity of ongoing chronic arthritis pain are explained by trait anxiety. NeuroImage Clin 12: 269\u2013276.","journal-title":"NeuroImage Clin"},{"key":"BFnpp2017110_CR18","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.coph.2005.10.001","volume":"6","author":"V Crunelli","year":"2006","unstructured":"Crunelli V, Emri Z, Leresche N (2006). Unravelling the brain targets of gamma-hydroxybutyric acid. Curr Opin Pharmacol 6: 44\u201352.","journal-title":"Curr Opin Pharmacol"},{"key":"BFnpp2017110_CR19","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nn1181","volume":"7","author":"HG Cruz","year":"2004","unstructured":"Cruz HG, Ivanova T, Lunn ML, Stoffel M, Slesinger PA, Luscher C (2004). Bi-directional effects of GABA(B) receptor agonists on the mesolimbic dopamine system. Nat Neurosci 7: 153\u2013159.","journal-title":"Nat Neurosci"},{"key":"BFnpp2017110_CR20","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1002\/mrm.21790","volume":"60","author":"W Dai","year":"2008","unstructured":"Dai W, Garcia D, de Bazelaire C, Alsop DC (2008). Continuous flow-driven inversion for arterial spin labeling using pulsed radio frequency and gradient fields. Magn Reson Med 60: 1488\u20131497.","journal-title":"Magn Reson Med"},{"key":"BFnpp2017110_CR21","doi-asserted-by":"crossref","first-page":"e71461","DOI":"10.1371\/journal.pone.0071461","volume":"8","author":"N Denier","year":"2013","unstructured":"Denier N, Gerber H, Vogel M, Klarhofer M, Riecher-Rossler A, Wiesbeck GA et al (2013). Reduction in cerebral perfusion after heroin administration: a resting state arterial spin labeling study. PLoS ONE 8: e71461.","journal-title":"PLoS ONE"},{"key":"BFnpp2017110_CR22","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/WCO.0b013e32832d9505","volume":"22","author":"JA Detre","year":"2009","unstructured":"Detre JA, Wang J, Wang Z, Rao H (2009). Arterial spin-labeled perfusion MRI in basic and clinical neuroscience. Curr Opin Neurol 22: 348\u2013355.","journal-title":"Curr Opin Neurol"},{"key":"BFnpp2017110_CR23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0022-3565(24)37762-6","volume":"287","author":"G Di Giovanni","year":"1998","unstructured":"Di Giovanni G, Di Mascio M, Di Matteo V, Esposito E (1998). Effects of acute and repeated administration of amisulpride, a dopamine D2\/D3 receptor antagonist, on the electrical activity of midbrain dopaminergic neurons. J Pharmacol Exp Therap 287: 51\u201357.","journal-title":"J Pharmacol Exp Therap"},{"key":"BFnpp2017110_CR24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.pscychresns.2010.01.009","volume":"182","author":"B Duhameau","year":"2010","unstructured":"Duhameau B, Ferre JC, Jannin P, Gauvrit JY, Verin M, Millet B et al (2010). Chronic and treatment-resistant depression: a study using arterial spin labeling perfusion MRI at 3Tesla. Psychiatry Res 182: 111\u2013116.","journal-title":"Psychiatry Res"},{"key":"BFnpp2017110_CR25","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/BF00173208","volume":"348","author":"G Engberg","year":"1993","unstructured":"Engberg G, Nissbrandt H (1993). Gamma-Hydroxybutyric acid (GHBA) induces pacemaker activity and inhibition of substantia nigra dopamine neurons by activating GABAB-receptors. Naunyn Schmiedebergs Arch Pharmacol 348: 491\u2013497.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"unstructured":"First MB, Spitzer RL, Gibbon M, Williams JBW (2002) Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Non-Patient. Biometrics Research, New York State Psychiatric Institute: New York.","key":"BFnpp2017110_CR26"},{"key":"BFnpp2017110_CR27","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/mrm.1910330508","volume":"33","author":"SD Forman","year":"1995","unstructured":"Forman SD, Cohen JD, Fitzgerald M, Eddy WF, Mintun MA, Noll DC (1995). Improved assessment of significant activation in functional magnetic resonance imaging (fMRI): use of a cluster-size threshold. Magn Reson Med 33: 636\u2013647.","journal-title":"Magn Reson Med"},{"key":"BFnpp2017110_CR28","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.drugalcdep.2012.03.016","volume":"125","author":"TR Franklin","year":"2012","unstructured":"Franklin TR, Shin J, Jagannathan K, Suh JJ, Detre JA, O'Brien CP et al (2012). Acute baclofen diminishes resting baseline blood flow to limbic structures: a perfusion fMRI study. Drug Alcohol Depend 125: 60\u201366.","journal-title":"Drug Alcohol Depend"},{"key":"BFnpp2017110_CR29","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.drugalcdep.2011.01.015","volume":"117","author":"TR Franklin","year":"2011","unstructured":"Franklin TR, Wang Z, Sciortino N, Harper D, Li Y, Hakun J et al (2011). Modulation of resting brain cerebral blood flow by the GABA B agonist, baclofen: a longitudinal perfusion fMRI study. Drug Alcohol Depend 117: 176\u2013183.","journal-title":"Drug Alcohol Depend"},{"key":"BFnpp2017110_CR30","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.nbd.2012.05.008","volume":"52","author":"CH Fu","year":"2013","unstructured":"Fu CH, Steiner H, Costafreda SG (2013). Predictive neural biomarkers of clinical response in depression: a meta-analysis of functional and structural neuroimaging studies of pharmacological and psychological therapies. Neurobiol Dis 52: 75\u201383.","journal-title":"Neurobiol Dis"},{"key":"BFnpp2017110_CR31","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF02191883","volume":"244","author":"L Gallimberti","year":"1994","unstructured":"Gallimberti L, Schifano F, Forza G, Miconi L, Ferrara SD (1994). Clinical efficacy of gamma-hydroxybutyric acid in treatment of opiate withdrawal. Eur Arch Psychiatry Clin Neurosci 244: 113\u2013114.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"BFnpp2017110_CR32","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0006-8993(03)02865-8","volume":"979","author":"GG Gould","year":"2003","unstructured":"Gould GG, Mehta AK, Frazer A, Ticku MK (2003). Quantitative autoradiographic analysis of the new radioligand [(3)H](2E)-(5-hydroxy-5,7,8,9-tetrahydro-6H-benzo[a][7]annulen-6-ylidene) ethanoic acid ([(3)H]NCS-382) at gamma-hydroxybutyric acid (GHB) binding sites in rat brain. Brain Res 979: 51\u201356.","journal-title":"Brain Res"},{"key":"BFnpp2017110_CR33","doi-asserted-by":"crossref","first-page":"20130607","DOI":"10.1098\/rstb.2013.0607","volume":"369","author":"T Gould","year":"2014","unstructured":"Gould T, Chen L, Emri Z, Pirttimaki T, Errington AC, Crunelli V et al (2014). GABA(B) receptor-mediated activation of astrocytes by gamma-hydroxybutyric acid. Philos Trans R Soc Lond B Biol Sci 369: 20130607.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"BFnpp2017110_CR34","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1037\/a0038101","volume":"141","author":"C Harshaw","year":"2015","unstructured":"Harshaw C (2015). Interoceptive dysfunction: toward an integrated framework for understanding somatic and affective disturbance in depression. Psychol Bull 141: 311\u2013363.","journal-title":"Psychol Bull"},{"key":"BFnpp2017110_CR35","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jaac.2013.07.008","volume":"52","author":"TC Ho","year":"2013","unstructured":"Ho TC, Wu J, Shin DD, Liu TT, Tapert SF, Yang G et al (2013). Altered cerebral perfusion in executive, affective, and motor networks during adolescent depression. J Am Acad Child Adolesc Psychiatry 52: 1076\u20131091 e1072.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"BFnpp2017110_CR36","doi-asserted-by":"crossref","first-page":"3936","DOI":"10.1002\/art.37685","volume":"64","author":"MA Howard","year":"2012","unstructured":"Howard MA, Sanders D, Krause K, O'Muircheartaigh J, Fotopoulou A, Zelaya F et al (2012). Alterations in resting-state regional cerebral blood flow demonstrate ongoing pain in osteoarthritis: an arterial spin-labeled magnetic resonance imaging study. Arthritis Rheum 64: 3936\u20133946.","journal-title":"Arthritis Rheum"},{"key":"BFnpp2017110_CR37","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/nn2003","volume":"10","author":"C Iadecola","year":"2007","unstructured":"Iadecola C, Nedergaard M (2007). Glial regulation of the cerebral microvasculature. Nat Neurosci 10: 1369\u20131376.","journal-title":"Nat Neurosci"},{"key":"BFnpp2017110_CR38","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/gps.1980","volume":"23","author":"J Ishizaki","year":"2008","unstructured":"Ishizaki J, Yamamoto H, Takahashi T, Takeda M, Yano M, Mimura M (2008). Changes in regional cerebral blood flow following antidepressant treatment in late-life depression. Int J Geriatr Psychiatry 23: 805\u2013811.","journal-title":"Int J Geriatr Psychiatry"},{"key":"BFnpp2017110_CR39","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0070-2153(06)79004-4","volume":"79","author":"D Jakovcevic","year":"2007","unstructured":"Jakovcevic D, Harder DR (2007). Role of astrocytes in matching blood flow to neuronal activity. Curr Top Dev Biol 79: 75\u201397.","journal-title":"Curr Top Dev Biol"},{"key":"BFnpp2017110_CR40","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/hup.2491","volume":"30","author":"M Kapitany-Foveny","year":"2015","unstructured":"Kapitany-Foveny M, Mervo B, Corazza O, Kokonyei G, Farkas J, Urban R et al (2015). Enhancing sexual desire and experience: an investigation of the sexual correlates of gamma-hydroxybutyrate (GHB) use. Hum Psychopharmacol 30: 276\u2013284.","journal-title":"Hum Psychopharmacol"},{"key":"BFnpp2017110_CR41","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1038\/nn2006","volume":"10","author":"G Labouebe","year":"2007","unstructured":"Labouebe G, Lomazzi M, Cruz HG, Creton C, Lujan R, Li M et al (2007). RGS2 modulates coupling between GABAB receptors and GIRK channels in dopamine neurons of the ventral tegmental area. Nat Neurosci 10: 1559\u20131568.","journal-title":"Nat Neurosci"},{"key":"BFnpp2017110_CR42","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/scan\/nsp001","volume":"7","author":"KH Lee","year":"2012","unstructured":"Lee KH, Siegle GJ (2012). Common and distinct brain networks underlying explicit emotional evaluation: a meta-analytic study. Soc Cogn Affect Neurosci 7: 521\u2013534.","journal-title":"Soc Cogn Affect Neurosci"},{"key":"BFnpp2017110_CR43","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/02791072.2008.10400639","volume":"40","author":"SJ Lee","year":"2008","unstructured":"Lee SJ, Levounis P (2008). Gamma hydroxybutyrate: an ethnographic study of recreational use and abuse. J Psychoactive Drugs 40: 245\u2013253.","journal-title":"J Psychoactive Drugs"},{"unstructured":"Lehrl S (2005) Mehrfachwahl-Wortschatz-Intelligenztest: MWT-B. Spitta-Verl.: Balingen.","key":"BFnpp2017110_CR44"},{"key":"BFnpp2017110_CR45","first-page":"CD006266","volume":"2","author":"MA Leone","year":"2010","unstructured":"Leone MA, Vigna-Taglianti F, Avanzi G, Brambilla R, Faggiano F (2010). Gamma-hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses. Cochrane Database Syst Rev 2: CD006266.","journal-title":"Cochrane Database Syst Rev"},{"key":"BFnpp2017110_CR46","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/bcp.12863","volume":"81","author":"ME Liechti","year":"2016","unstructured":"Liechti ME, Quednow BB, Liakoni E, Dornbierer D, von Rotz R, Gachet MS et al (2016). Pharmacokinetics and pharmacodynamics of gamma-hydroxybutyrate in healthy subjects. Br J Clin Pharmacol 81: 980\u2013988.","journal-title":"Br J Clin Pharmacol"},{"key":"BFnpp2017110_CR47","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1016\/j.neuroimage.2011.11.013","volume":"59","author":"L Lindgren","year":"2012","unstructured":"Lindgren L, Westling G, Brulin C, Lehtipalo S, Andersson M, Nyberg L (2012). Pleasant human touch is represented in pregenual anterior cingulate cortex. NeuroImage 59: 3427\u20133432.","journal-title":"NeuroImage"},{"key":"BFnpp2017110_CR48","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.pain.2012.09.016","volume":"154","author":"J Liu","year":"2013","unstructured":"Liu J, Hao Y, Du M, Wang X, Zhang J, Manor B et al (2013). Quantitative cerebral blood flow mapping and functional connectivity of postherpetic neuralgia pain: a perfusion fMRI study. Pain 154: 110\u2013118.","journal-title":"Pain"},{"key":"BFnpp2017110_CR49","doi-asserted-by":"crossref","first-page":"128","DOI":"10.2105\/AJPH.82.1.128-a","volume":"82","author":"S Luby","year":"1992","unstructured":"Luby S, Jones J, Zalewski A (1992). GHB use in South Carolina. Am J Public Health 82: 128.","journal-title":"Am J Public Health"},{"key":"BFnpp2017110_CR50","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1148\/radiol.2512081548","volume":"251","author":"S Lui","year":"2009","unstructured":"Lui S, Parkes LM, Huang X, Zou K, Chan RC, Yang H et al (2009). Depressive disorders: focally altered cerebral perfusion measured with arterial spin-labeling MR imaging. Radiology 251: 476\u2013484.","journal-title":"Radiology"},{"key":"BFnpp2017110_CR51","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0301-0082(96)00064-0","volume":"51","author":"M Maitre","year":"1997","unstructured":"Maitre M (1997). The gamma-hydroxybutyrate signalling system in brain: organization and functional implications. Prog Neurobiol 51: 337\u2013361.","journal-title":"Prog Neurobiol"},{"key":"BFnpp2017110_CR52","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0014-2999(94)90248-8","volume":"256","author":"M Maitre","year":"1994","unstructured":"Maitre M, Ratomponirina C, Gobaille S, Hode Y, Hechler V (1994). Displacement of [3H] gamma-hydroxybutyrate binding by benzamide neuroleptics and prochlorperazine but not by other antipsychotics. Eur J Pharmacol 256: 211\u2013214.","journal-title":"Eur J Pharmacol"},{"key":"BFnpp2017110_CR53","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/nbm.2911","volume":"26","author":"N Maleki","year":"2013","unstructured":"Maleki N, Brawn J, Barmettler G, Borsook D, Becerra L (2013). Pain response measured with arterial spin labeling. NMR Biomed 26: 664\u2013673.","journal-title":"NMR Biomed"},{"key":"BFnpp2017110_CR54","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.pneurobio.2009.07.004","volume":"89","author":"M Mamelak","year":"2009","unstructured":"Mamelak M (2009). Narcolepsy and depression and the neurobiology of gammahydroxybutyrate. Prog Neurobiol 89: 193\u2013219.","journal-title":"Prog Neurobiol"},{"key":"BFnpp2017110_CR55","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1176\/ajp.156.5.675","volume":"156","author":"HS Mayberg","year":"1999","unstructured":"Mayberg HS, Liotti M, Brannan SK, McGinnis S, Mahurin RK, Jerabek PA et al (1999). Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am J Psychiatry 156: 675\u2013682.","journal-title":"Am J Psychiatry"},{"key":"BFnpp2017110_CR56","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/eat.20798","volume":"44","author":"SL McElroy","year":"2011","unstructured":"McElroy SL, Guerdjikova AI, Winstanley EL, O'Melia AM, Mori N, Keck PE Jr. et al (2011). Sodium oxybate in the treatment of binge eating disorder: an open-label, prospective study. Int J Eat Disord 44: 262\u2013268.","journal-title":"Int J Eat Disord"},{"key":"BFnpp2017110_CR57","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/jamapsychiatry.2013.143","volume":"70","author":"CL McGrath","year":"2013","unstructured":"McGrath CL, Kelley ME, Holtzheimer PE, Dunlop BW, Craighead WE, Franco AR et al (2013). Toward a neuroimaging treatment selection biomarker for major depressive disorder. JAMA Psychiatry 70: 821\u2013829.","journal-title":"JAMA Psychiatry"},{"unstructured":"Mesulam M (2000). Behavioural neuroanatomy: large-scale networks, association cortex, frontal syndromes, the limbic system, and the hemispheric specializations. In: Mesulam M (ed). Principles of Behavioural and Cognitive Neurology. Oxford University Press: Oxford.","key":"BFnpp2017110_CR58"},{"key":"BFnpp2017110_CR59","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.drugalcdep.2013.08.015","volume":"133","author":"R Migliorini","year":"2013","unstructured":"Migliorini R, Stewart JL, May AC, Tapert SF, Paulus MP (2013). What do you feel? Adolescent drug and alcohol users show altered brain response to pleasant interoceptive stimuli. Drug Alcohol Depend 133: 661\u2013668.","journal-title":"Drug Alcohol Depend"},{"key":"BFnpp2017110_CR60","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1080\/105504901750532111","volume":"10","author":"K Miotto","year":"2001","unstructured":"Miotto K, Darakjian J, Basch J, Murray S, Zogg J, Rawson R (2001). Gamma-hydroxybutyric acid: patterns of use, effects and withdrawal. Am J Addict 10: 232\u2013241.","journal-title":"Am J Addict"},{"key":"BFnpp2017110_CR61","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1471-4159.2010.06901.x","volume":"115","author":"FA Nasrallah","year":"2010","unstructured":"Nasrallah FA, Maher AD, Hanrahan JR, Balcar VJ, Rae CD (2010). gamma-Hydroxybutyrate and the GABAergic footprint: a metabolomic approach to unpicking the actions of GHB. J Neurochem 115: 58\u201367.","journal-title":"J Neurochem"},{"key":"BFnpp2017110_CR62","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1089\/brain.2012.0101","volume":"2","author":"A Orosz","year":"2012","unstructured":"Orosz A, Jann K, Federspiel A, Horn H, Hofle O, Dierks T et al (2012). Reduced cerebral blood flow within the default-mode network and within total gray matter in major depression. Brain Connect 2: 303\u2013310.","journal-title":"Brain Connect"},{"key":"BFnpp2017110_CR63","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jad.2014.04.032","volume":"165","author":"M Ota","year":"2014","unstructured":"Ota M, Noda T, Sato N, Hattori K, Teraishi T, Hori H et al (2014). Characteristic distributions of regional cerebral blood flow changes in major depressive disorder patients: a pseudo-continuous arterial spin labeling (pCASL) study. J Affect Disord 165: 59\u201363.","journal-title":"J Affect Disord"},{"key":"BFnpp2017110_CR64","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.pain.2007.06.021","volume":"136","author":"DG Owen","year":"2008","unstructured":"Owen DG, Bureau Y, Thomas AW, Prato FS, St Lawrence KS (2008). Quantification of pain-induced changes in cerebral blood flow by perfusion MRI. Pain 136: 85\u201396.","journal-title":"Pain"},{"key":"BFnpp2017110_CR65","first-page":"143","volume":"5","author":"JJ Palamar","year":"2014","unstructured":"Palamar JJ, Kiang MV, Storholm ED, Halkitis PN (2014). A qualitative descriptive study of perceived sexual effects of club drug use in gay and bisexual men. Psychol Sex 5: 143\u2013160.","journal-title":"Psychol Sex"},{"key":"BFnpp2017110_CR66","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/026988110001400106","volume":"14","author":"M Papp","year":"2000","unstructured":"Papp M, Wieronska J (2000). Antidepressant-like activity of amisulpride in two animal models of depression. J Psychopharmacol 14: 46\u201352.","journal-title":"J Psychopharmacol"},{"key":"BFnpp2017110_CR67","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00429-010-0258-9","volume":"214","author":"MP Paulus","year":"2010","unstructured":"Paulus MP, Stein MB (2010). Interoception in anxiety and depression. Brain Struct Funct 214: 451\u2013463.","journal-title":"Brain Struct Funct"},{"key":"BFnpp2017110_CR68","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0022-3565(24)36394-3","volume":"280","author":"G Perrault","year":"1997","unstructured":"Perrault G, Depoortere R, Morel E, Sanger DJ, Scatton B (1997). Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2\/D3 dopamine receptor antagonist activity and limbic selectivity. J Pharmacol Exp Therap 280: 73\u201382.","journal-title":"J Pharmacol Exp Therap"},{"key":"BFnpp2017110_CR69","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.neuroscience.2004.11.021","volume":"131","author":"M Pistis","year":"2005","unstructured":"Pistis M, Muntoni AL, Pillolla G, Perra S, Cignarella G, Melis M et al (2005). Gamma-hydroxybutyric acid (GHB) and the mesoaccumbens reward circuit: evidence for GABA(B) receptor-mediated effects. Neuroscience 131: 465\u2013474.","journal-title":"Neuroscience"},{"key":"BFnpp2017110_CR70","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/sj.npp.1300396","volume":"29","author":"BB Quednow","year":"2004","unstructured":"Quednow BB, Kuhn KU, Hoenig K, Maier W, Wagner M (2004). Prepulse inhibition and habituation of acoustic startle response in male MDMA ('ecstasy') users, cannabis users, and healthy controls. Neuropsychopharmacology 29: 982\u2013990.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2017110_CR71","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000079104","volume":"50","author":"G Racagni","year":"2004","unstructured":"Racagni G, Canonico PL, Ravizza L, Pani L, Amore M (2004). Consensus on the use of substituted benzamides in psychiatric patients. Neuropsychobiology 50: 134\u2013143.","journal-title":"Neuropsychobiology"},{"key":"BFnpp2017110_CR72","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.cortex.2013.12.005","volume":"62","author":"ET Rolls","year":"2015","unstructured":"Rolls ET (2015). Limbic systems for emotion and for memory, but no single limbic system. Cortex 62: 119\u2013157.","journal-title":"Cortex"},{"key":"BFnpp2017110_CR73","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/cercor\/13.3.308","volume":"13","author":"ET Rolls","year":"2003","unstructured":"Rolls ET, O'Doherty J, Kringelbach ML, Francis S, Bowtell R, McGlone F (2003). Representations of pleasant and painful touch in the human orbitofrontal and cingulate cortices. Cereb Cortex 13: 308\u2013317.","journal-title":"Cereb Cortex"},{"key":"BFnpp2017110_CR74","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.neuroimage.2016.06.031","volume":"139","author":"U Sailer","year":"2016","unstructured":"Sailer U, Triscoli C, Haggblad G, Hamilton P, Olausson H, Croy I (2016). Temporal dynamics of brain activation during 40 minutes of pleasant touch. NeuroImage 139: 360\u2013367.","journal-title":"NeuroImage"},{"key":"BFnpp2017110_CR75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00004850-200201000-00001","volume":"17","author":"P Saleem","year":"2002","unstructured":"Saleem P, Olie JP, Loo H (2002). Social functioning and quality of life in the schizophrenic patient: advantages of amisulpride. Int Clin Psychopharmacol 17: 1\u20138.","journal-title":"Int Clin Psychopharmacol"},{"key":"BFnpp2017110_CR76","first-page":"102","volume":"36","author":"BJ Salmeron","year":"2002","unstructured":"Salmeron BJ, Stein EA (2002). Pharmacological applications of magnetic resonance imaging. Psychopharmacol Bull 36: 102\u2013129.","journal-title":"Psychopharmacol Bull"},{"key":"BFnpp2017110_CR77","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.neuroimage.2004.12.002","volume":"25","author":"CF Schmidt","year":"2005","unstructured":"Schmidt CF, Degonda N, Luechinger R, Henke K, Boesiger P (2005). Sensitivity-encoded (SENSE) echo planar fMRI at 3T in the medial temporal lobe. NeuroImage 25: 625\u2013641.","journal-title":"NeuroImage"},{"key":"BFnpp2017110_CR78","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nn.3969","volume":"18","author":"AR Segerdahl","year":"2015","unstructured":"Segerdahl AR, Mezue M, Okell TW, Farrar JT, Tracey I (2015). The dorsal posterior insula subserves a fundamental role in human pain. Nat Neurosci 18: 499\u2013500.","journal-title":"Nat Neurosci"},{"key":"BFnpp2017110_CR79","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/AJP.0000000000000295","volume":"32","author":"M Shokouhi","year":"2016","unstructured":"Shokouhi M, Davis KD, Moulin DE, Morley-Forster P, Nielson WR, Bureau Y et al (2016). Basal ganglia perfusion in fibromyalgia is related to pain disability and disease impact: an arterial spin labeling study. Clin J Pain 32: 495\u2013505.","journal-title":"Clin J Pain"},{"key":"BFnpp2017110_CR80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neubiorev.2015.08.003","volume":"57","author":"R Smith","year":"2015","unstructured":"Smith R, Lane RD (2015). The neural basis of one's own conscious and unconscious emotional states. Neurosci Biobehav Rev 57: 1\u201329.","journal-title":"Neurosci Biobehav Rev"},{"key":"BFnpp2017110_CR81","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1046\/j.1471-4159.2000.0751986.x","volume":"75","author":"OC Snead 3rd","year":"2000","unstructured":"Snead OC 3rd (2000). Evidence for a G protein-coupled gamma-hydroxybutyric acid receptor. J Neurochem 75: 1986\u20131996.","journal-title":"J Neurochem"},{"key":"BFnpp2017110_CR82","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1136\/annrheumdis-2011-200418","volume":"71","author":"M Spaeth","year":"2012","unstructured":"Spaeth M, Bennett RM, Benson BA, Wang YG, Lai C, Choy EH (2012). Sodium oxybate therapy provides multidimensional improvement in fibromyalgia: results of an international phase 3 trial. Ann Rheum Dis 71: 935\u2013942.","journal-title":"Ann Rheum Dis"},{"key":"BFnpp2017110_CR83","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.drugalcdep.2015.07.009","volume":"154","author":"JL Stewart","year":"2015","unstructured":"Stewart JL, May AC, Tapert SF, Paulus MP (2015). Hyperactivation to pleasant interoceptive stimuli characterizes the transition to stimulant addiction. Drug Alcohol Depend 154: 264\u2013270.","journal-title":"Drug Alcohol Depend"},{"key":"BFnpp2017110_CR84","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.drugalcdep.2007.07.009","volume":"92","author":"HR Sumnall","year":"2008","unstructured":"Sumnall HR, Woolfall K, Edwards S, Cole JC, Beynon CM (2008). Use, function, and subjective experiences of gamma-hydroxybutyrate (GHB). Drug Alcohol Depend 92: 286\u2013290.","journal-title":"Drug Alcohol Depend"},{"key":"BFnpp2017110_CR85","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jad.2009.06.003","volume":"121","author":"T Takahashi","year":"2010","unstructured":"Takahashi T, Yucel M, Lorenzetti V, Tanino R, Whittle S, Suzuki M et al (2010). Volumetric MRI study of the insular cortex in individuals with current and past major depression. J Affect Disord 121: 231\u2013238.","journal-title":"J Affect Disord"},{"key":"BFnpp2017110_CR86","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1002\/hbm.20705","volume":"30","author":"KS Taylor","year":"2009","unstructured":"Taylor KS, Seminowicz DA, Davis KD (2009). Two systems of resting state connectivity between the insula and cingulate cortex. Hum Brain Map 30: 2731\u20132745.","journal-title":"Hum Brain Map"},{"key":"BFnpp2017110_CR87","first-page":"309","volume":"16","author":"R Teltzrow","year":"2012","unstructured":"Teltzrow R, Bosch OG (2012). Ecstatic anaesthesia: Ketamine and GHB between medical use and self-experimentation. Appl Cardiopulm Pathophysiol 16: 309\u2013321.","journal-title":"Appl Cardiopulm Pathophysiol"},{"key":"BFnpp2017110_CR88","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/sj.clpt.6100037","volume":"81","author":"D Thai","year":"2007","unstructured":"Thai D, Dyer JE, Jacob P, Haller CA (2007). Clinical pharmacology of 1,4-butanediol and gamma-hydroxybutyrate after oral 1,4-butanediol administration to healthy volunteers. Clin Pharmacol Therap 81: 178\u2013184.","journal-title":"Clin Pharmacol Therap"},{"key":"BFnpp2017110_CR89","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00213-013-3091-z","volume":"229","author":"R Viviani","year":"2013","unstructured":"Viviani R, Graf H, Wiegers M, Abler B (2013). Effects of amisulpride on human resting cerebral perfusion. Psychopharmacology 229: 95\u2013103.","journal-title":"Psychopharmacology"},{"key":"BFnpp2017110_CR90","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1124\/jpet.110.172577","volume":"337","author":"DJ Wang","year":"2011","unstructured":"Wang DJ, Chen Y, Fernandez-Seara MA, Detre JA (2011). Potentials and challenges for arterial spin labeling in pharmacological magnetic resonance imaging. J Pharmacol Exp Therap 337: 359\u2013366.","journal-title":"J Pharmacol Exp Therap"},{"key":"BFnpp2017110_CR91","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3389\/fnbeh.2015.00082","volume":"9","author":"C Wiebking","year":"2015","unstructured":"Wiebking C, de Greck M, Duncan NW, Tempelmann C, Bajbouj M, Northoff G (2015). Interoception in insula subregions as a possible state marker for depression-an exploratory fMRI study investigating healthy, depressed and remitted participants. Front Behav Neurosci 9: 82.","journal-title":"Front Behav Neurosci"},{"key":"BFnpp2017110_CR92","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.neuroimage.2012.05.012","volume":"62","author":"J Zaki","year":"2012","unstructured":"Zaki J, Davis JI, Ochsner KN (2012). Overlapping activity in anterior insula during interoception and emotional experience. NeuroImage 62: 493\u2013499.","journal-title":"NeuroImage"},{"key":"BFnpp2017110_CR93","first-page":"109","volume":"17","author":"R Zerbib","year":"1992","unstructured":"Zerbib R, Pierrefiche G, Ferran C, Laborit T (1992). Potential antidepressant activity of gamma-hydroxybutyrate in the mouse \u2018behavioral despair\u2019 test: correlation with the central dopaminergic system. Res Commun Psychol Psychiat Behav 17: 109\u2013122.","journal-title":"Res Commun Psychol Psychiat Behav"},{"key":"BFnpp2017110_CR94","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pbb.2015.07.014","volume":"137","author":"L Zvejniece","year":"2015","unstructured":"Zvejniece L, Vavers E, Svalbe B, Veinberg G, Rizhanova K, Liepins V et al (2015). R-phenibut binds to the alpha2-delta subunit of voltage-dependent calcium channels and exerts gabapentin-like anti-nociceptive effects. Pharmacol Biochem Behav 137: 23\u201329.","journal-title":"Pharmacol Biochem Behav"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/npp2017110.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2017110","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/npp.2017.110","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/npp2017110.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T21:43:40Z","timestamp":1750283020000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npp2017110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,31]]},"references-count":94,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["BFnpp2017110"],"URL":"https:\/\/doi.org\/10.1038\/npp.2017.110","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"type":"print","value":"0893-133X"},{"type":"electronic","value":"1740-634X"}],"subject":[],"published":{"date-parts":[[2017,5,31]]},"assertion":[{"value":"24 January 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}